Open AccessASH ANNUAL MEETING: Brentuximab Shows High Response Rates in Relapsed Refractory Lymphomas
Author(s) -
Robert H. Carlson
Publication year - 2011
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000394484.85823.91
Subject(s) - brentuximab vedotin , medicine , oncology , refractory (planetary science) , lymphoma , anaplastic large cell lymphoma , hematology , hodgkin lymphoma , physics , astrobiology